Company Search:
Advanced Search
Sponsored Links
Seoulin Bioscience Company Limited Company Snapshot
Seoulin Bioscience Company Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Seoulin Bioscience Company Limited with three other companies in this sector in KOREA (SOUTH) : Medipost Co Ltd (2019 sales of 45.81 billion Korean Won [US$37.20 million] of which 49% was Umbilical Cord Blood), Bioneer Corporation (36.29 billion Korean Won [US$29.47 million] of which 50% was DNA/RNA molecular diagnostic kits), and Legochem Biosciences Inc (57.50 billion Korean Won [US$46.69 million] of which 55% was New Drugs R & D).

Sales Analysis. During the year ended December of 2019, sales at Seoulin Bioscience Company Limited were 54.41 billion Korean Won (US$44.18 million). This is an increase of 9.1% versus 2018, when the company's sales were 49.88 billion Korean Won . Sales of Biotechnology saw an increase of 10.2% in 2019, from 45.83 billion Korean Won to 50.52 billion Korean Won . Not all segments of Seoulin Bioscience Company Limited experienced an increase in sales in 2019: sales of Healthcare fell 3.7% to 3.89 billion Korean Won .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Seoulin Bioscience Company Limited
  Stock Performance Chart for Seoulin Bioscience Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 11,200
(Figures in Korean Won )
1 Week -7.1%   13 Weeks -3.0%  
4 Weeks 11.4%   52 Weeks 26.2%  
Seoulin Bioscience Company Limited Key Data:
  Ticker: 038070 Country: Korea (South)
  Exchanges: SEO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 54,409,607,077
(Year Ending Jan 2020).
Employees: 91
  Currency: Korean Won Market Cap: 86,145,964,800
  Fiscal Yr Ends: December Shares Outstanding: 7,691,604
  Share Type: Common Closely Held Shares: 2,277,642
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.